Canonical transient receptor potential (TRPC) receptors are Ca 2+ -permeable cation channels that have a variety of physiological functions and may be involved in neuronal development and plasticity. We investigated the expression profile of TRPC channels in adult rat dorsal root ganglia (DRG) after nerve injury and examined the role of TRPC4 in neurite outgrowth in cultured DRG neurons.
Canonical transient receptor potential (TRPC) receptors are Ca 2+ -permeable cation channels that have a variety of physiological functions and may be involved in neuronal development and plasticity. We investigated the expression profile of TRPC channels in adult rat dorsal root ganglia (DRG) after nerve injury and examined the role of TRPC4 in neurite outgrowth in cultured DRG neurons.
Sciatic nerve transection and microinjection of db-cAMP (dibutyryl cyclic adenosine monophosphate) were employed to induce axonal regeneration in vivo. TRPC4 mRNA was significantly increased whereas TRPC1, TRPC3, TRPC6 and TRPC7 remained unaltered after nerve injury or db-cAMP microinjection.
The increases in TRPC4 transcript and protein were transient with maximal levels reached at 2d or 7d, respectively. In addition, TRPC4 transcript in ND7/23 and NDC cells, hybrid cell lines derived from neonatal DRG and neuroblastoma, was substantially increased on differentiation, characterized by neurite outgrowth.
In adult DRG, TRPC4 immunoreactivity was found in small and large neurons, and nerve injury increased the number of TRPC4 immunoreactive cells, particularly in large neurons. TRPC4 immunoreactivity was present in growth cones at various stages of DRG neurite outgrowth in vitro. Suppression of TRPC4 by a specific siRNA (small interfering RNA) or antisense significantly reduced the length of neurites in cultured DRG neurons. Expression of shRNA (short hairpin RNA) significantly down-regulated TRPC4 protein level and shortened neurite lengths in differentiated ND7/23 cells. The reduction in neurite lengths in ND7/23 cells was rescued by over-expression of human TRPC4 (hTRPC4). Our results suggest that TRPC4 contributes to axonal regeneration after nerve injury.
It has been recognized for years that Ca 2+ is a critical mediator of the pathfinding and elongation of growing axons through its regulation of cytoskeletal molecules and membrane dynamics (1, 2) . Several Ca 2+permeable ion channels including voltageoperated calcium channels, ligand-gated channels and store-operated channels contribute to Ca 2+ transients in growing axons. Recently, members of the transient receptor potential (TRP) family have been identified as new Ca 2+ influx pathways.
For example, TRPC1 homologue mediates Ca 2+ increase and thus growth cone turning induced by the guidance cue of BDNF (brain-derived neurotrophic factor) and by the repellent factor of myelin-associated glycoprotein in Xenopus spinal neurons (3, 4) . Thus, we asked whether TRPC channels might play a role in mammalian nerve regeneration after injury.
TRP receptors can be classified into seven subfamilies: TRPC, TRPV, TRPM, TRPN, TRPA, TRPP and TRPML (5, 6) . The mammalian TRPC (canonical) subfamily consists of seven members (TRPC1-TRPC7) that bear structural similarity to Drosophila TRP photoreceptors. TRPC channels serve a wide range of physiological functions ranging from proliferation of vascular smooth muscle (7) to mechanical sensory transduction (8) . Although it remains controversial whether TRPC receptors function as store-operated Ca 2+ channels, it is generally accepted that they are activated by Gα q -coupled receptors and tyrosine kinaselinked receptors through phospholipase C (PLC) activation or diacylglycerol (DAG) production (6) . For example, TRPC3 is activated in a PLCdependent manner following the activation of TrkB by BDNF in CNS neurons (9, 10) .
Injury to the peripheral axons of primary sensory neurons induces changes in the cell bodies which support axonal regeneration. For example, the re-growth of injured axons in dorsal spinal roots or from dorsal columns of the spinal cord is enhanced strongly by a concomitant peripheral nerve injury (11, 12) . Application of exogenous cAMP to DRG effectively mimics this conditioning effect both in vitro and in vivo (13) (14) (15) . However, the molecular changes within injured neurons which mediate this growth potential are only partially understood. In the present study, we have investigated possible changes in the expression of TRPC genes after sciatic nerve transection and intra-ganglionic microinjection of db-cAMP. We have found a marked transient increase in TRPC4 transcript and protein in DRG cells following either treatment. The elongation of neurites in DRG neurons was significantly impaired when TRPC4 expression was suppressed by siRNA (small interfering RNA) or antisense. Thus, our data have revealed a close relationship between TRPC4 expression and axonal regeneration in adult DRG neurons.
EXPERIMENTAL PROCEDURES
Conditioning nerve lesion and intraganglionic injection-All experimental protocols were approved by the local animal care committee, in accordance with U.K. Home Office regulations. Female Sprague-Dawley rats (approximately 250g) were anesthetized and the left sciatic nerve was exposed and transected at mid-thigh level. The contralateral sciatic nerve was exposed, but not transected. For DRG microinjection, a small laminectomy was performed to expose the left L5 DRG and 1.5 μl db-cAMP (dibutyryl cyclic adenosine monophosphate, Sigma-Aldrich, St Louis, MO) at the concentration of 33 mM in PBS or a similar amount of PBS was injected into the exposed DRG using a Hamilton syringe with a 30G needle. The overlying skin and muscle was sutured and the animal was allowed to recover.
DRG cell line culture and transfection-ND7/23 and NDC are hybrid cell lines derived from neonatal rat DRG neurons fused with a mouse neuroblastoma (16) . The cell lines were used for some experiments in preference to DRG primary cell cultures (see later) because of the greater ease of transfection. The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 50 units/ml penicillin, 50 μg/ml streptomycin and 2 mM glutamine at 37°C in humidified air with 5% CO 2 . A DMEMbased medium containing 10% horse serum, 5% FBS, penicillin/streptomycin and glutamine was used to culture PC12 cells. NGF 7s (100 ng/ml) was added to differentiate PC12 cells.
Two complementary oligonucleotides specific to rat TRPC4 (17) were ordered from Invitrogen. The hairpin RNA oligonucleotides were annealed and ligated into the linearized pSilencer 3.1 H1 hygro vector as described by the manufacturer (Ambion Inc.). The inserts were sequenced to confirm that there were no unwanted mutations. Transfection of ND7/23 was carried out using siPORT XP-1 as directed by the manufacturer's instruction manual (Ambion Inc.). Cells were grown in 6-well plates to 40-60% confluence and each well was transfected with 1μg short hairpin RNA (shRNA) in antibiotic-free medium. Hygromycin (250 μg/ml) was added 24 hrs after transfection. For mock control, a mismatch hairpin oligonucleotide duplex was inserted into pSilencer 3.1 vector followed by similar transfection. A stable cell line was established in selection medium following the transfection of TRPC4 shRNA or mismatch duplex. Cells were then grown in 125μg/ml hygromycin for analysis.
Transfection of shRNA-expressing ND7/23 cells with human TRPC4 (hTRPC4, a generous gift from Dr. John Wood) was carried out using Lipofectamine 2000 (Invitrogen) as described by the manufacturer. For each 35-mm Petri dish, hTRPC4 (1μg) together with EGFP (0.3μg, Clontech) were mixed with diluted lipid reagent for 15 min at room temperature. Cells were incubated with the above complexes for 5 h at 37°C in humidified air with 5% CO 2 . GFP was used as a visual maker for hTRPC4-expressing cells.
To initiate differentiation, the cells were incubated in DMEM containing 0.5% FBS and stimulated with 100 ng/ml NGF 7s or 1 mM db-cAMP.
Cells were fixed 2 days after differentiation, immunostained for β-tubulin III (1:1000, Sigma) and the length of the longest neurites was measured with ImageJ software. Median lengths and frequency histograms of neurite lengths of 200-350 cells in three bins (<30, 30-100 and >100 μm) were analyzed. The statistical significance was examined using χ 2 analysis.
RT-PCR and quantitative Real-time PCR-Total RNA was extracted with Trizol ® Reagent (Invitrogen) from L4 and L5 DRG of rats subjected to the conditioning or the mock manipulation. Total RNA of DRG cell lines or PC12 cells was prepared similarly. First-strand cDNA was prepared from 1 μg of total RNA with random hexanucleotide primers using Superscript III ® reverse transcriptase (Invitrogen). The cDNA was amplified by PCR using TRPC1 and TRPC3-7 specific primers (17) . Each amplification reaction contained cDNA derived from 25 ng RNA, 1.5 mM MgCl 2 , 400 nM dNTP mix, 200 nM sense, 200 nM antisense primers and 0.125 μl Taq DNA polymerase (Sigma-Aldrich) in a final volume of 25 μl. Cycling conditions have been described previously (15) . An internal control of 18S ribosomal RNA (18S rRNA) was performed alongside the experimental samples. PCR products were run and visualized in 2% agarose gel containing ethidium bromide.
Quantitative real-time PCR was performed according to the protocol of the QIAGEN QuantiTectTM SYBR ® Green PCR kit (QIAGEN GmbH, Hilden, Germany) in a Rotor-Gene 3000TM thermocycler (Corbett Research, Sydney, Australia). Melting curves were generated after the last extension step to verify the specificity and identity of PCR products. Each sample was tested in triplicate. The expression level of TRPC transcripts was normalized to the expression of 18S rRNA and expressed as arbitrary units. When measuring 18S rRNA, the cDNAs were diluted 200 fold due to its abundance.
To compare the expression levels between different TRPC subunits, we calculated the absolute copy numbers of TRPC and 18S rRNA using standard curves generated with PCR products containing the target sequences.
Copy numbers of individual TRPC transcripts were then normalized to those of 18S rRNA (18) .
DRG neuron culture and transfection-DRG neurons were isolated from female Sprague-Dawley rats (~250 g) by methods similar to those described previously (19) . Briefly, rats were killed by inhalation of a rising concentration of CO 2 and cervical dislocation. Ganglia from the lumbar level were removed in Ca 2+ /Mg 2+ -free Hank's balanced salt solution. DRG neurons were dissociated by incubation in 0.125% collagenase XI (Sigma) at 37 °C for 2 hrs. The dispersed cells were suspended, seeded on poly-L-lysine-coated coverslips, and maintained in culture medium containing 0.3% bovine serum albumin, 1% N-2 supplement and penicillin/streptomycin in Ham's F-12 basal medium (all regents from Life Technologies). After 24 hrs, neurons were transfected with TRPC4-specific siRNA (sense TACCAAGAGGTGATGAGGATT and antisense 5' TCCTCATCACCTCTTGGTATT) with a fluorescein label at 5' end and mismatch control RNA duplexes (Block-it, Invitrogen) at the final concentration of 50 nM using oligofectamine (Invitrogen).
Cells were then maintained at 37 o C in a humidified atmosphere of 95% air and 5% CO 2. To quantify the length of neurites, DRG neurons were fixed 2 days after transfection, immunostained for β-tubulin III (1:1000, Sigma) and the length of the longest neurites of each cell was measured with ImageJ software. Previous studies indicate that a subpopulation of DRG neurons identified by Griffonia simplicifolia isolectin B4 (IB4) give rise to little neurite outgrowth in normal culture conditions (21) . Therefore, we excluded those cells whose longest neurites failed to reach twice the length of the cell bodies. Median lengths and frequency histograms of neurite lengths of approximately 100 cells were analyzed.
Immunohistochemistry-Sprague-Dawley rats were anaesthetized with an intraperitoneal injection of sodium pentobarbital (60 mg/kg, Sagatal, France) and then perfused with 0.9% saline followed by 4% paraformaldehyde in 0.1 M phosphate-buffer at 12hrs, 3d or 7d after left sciatic nerve axotomy. Two rats were used for each time point and two rats without sciatic nerve lesion were used as control. Cultured DRG neurons and ND7/23 cells were fixed in 4% paraformaldehyde, pH 7.4 for 15 min at room temperature. TRPC4 staining was visualized using the tyramide signal amplification technique. Briefly, sections were labeled with a rabbit polyclonal antibody against TRPC4 (1:1000, Alomone, Israel) overnight followed by incubation in donkey anti-rabbit biotin (1:400) for 90 min. Sections were then incubated in avidin-biotin peroxidase complex from an ABC kit (Vector Laboratories, CA, USA) for 60 min, followed by incubation in cyanine 3 tyramide solution (1:75, PerkinElmer Life and Analytical Sciences, USA) for 7 min. TRPC4 peptide antigen was added to control slides to test the specificity of the primary antibody.
Slides were also stained with mouse anti-200-kDa neurofilament (N52 clone, 1:5000, Sigma, Poole, U.K.) and rabbit anti-P2X 3 (1:1000, Neuromics) or rabbit anti-CGRP (1:1000) antibodies to visualize distinct DRG subpopulations. FITC-conjugated goat antirabbit Ig G (1:400, Jackson Labs) and AMICAconjugated goat anti-mouse Ig G (1:400, Jackson Labs) were added for 2 hrs following rinses with PBS. All slides were pre-blocked in 10% normal donkey serum containing 0.2% TritonX-100 for 1 hr. Primary antibodies were diluted in PBS containing 0.2% TritonX-100 and 0.1% sodium azide. Sections were viewed on a Leica epifluorescence microscope (Wetzlar, Germany) and micrographs were taken at 20x objective magnification. The total number of neurons per section was counted based on Hoechst labeling. Neurons showing TRPC4 immunoreactivity were counted and expressed as a percentage of total DRG neurons or a percentage of a subpopulation such as N52 positive or P2X 3 positive neurons. One-way ANOVA was used to compare the numbers of TRPC4 positive cells from 0 to 3d after nerve injury. For total DRG or TRPC4 immunoreactive cell size distribution, 250 DRG neurons were measured on randomly chosen sections using ImageJ software.
Confocal microscopy-DRG neurons or cell lines with TRPC4 labeling were examined using an upright Zeiss confocal laser scanning microscope system (LSM 510) and a 63x Plan Neofluor oil objective. Cells were scanned for cyanine 3 at 543 nm with an increment of 0.25 μm in the Z plane.
Immunoblotting-Sprague-Dawley rats were sacrificed at 4d, 7d or 14d after left sciatic nerve axotomy. Two rats were used for each time point and two rats without sciatic nerve lesion were used as control. The left L4 and L5 DRG were collected, cut into pieces using fine scissors and homogenized in 200 μl lysis buffer containing protease inhibitors (Roche Applied Science). For cell line preparations, cells were washed in cold PBS, pelleted and re-suspended in RIPA lysis buffer containing protease inhibitors. Samples were then solubilized by rotation at 4°C for overnight. The lysate was centrifuged at 13,000 g for 15 min and the supernatant was collected. Protein concentration was measured using DC protein assay (BioRad) and the lysates were subjected to electrophoresis on 6.5% SDS-PAGE gels, transferred onto PVDF membrane and blotted with polyclonal rabbit TRPC4 antibody (Alomone, 1:100) overnight at 4°C. Anti-rabbit immunoglobulin horseradish-linked secondary antibody (Amersham Pharmacia Biotech) was used at a final dilution of 1:5000 and the signal was detected with the ECL plus Western blotting detection system. The membranes were subsequently stripped and reblotted with mouse anti-actin antibody (1:500, Sigma). Protein levels of TRPC4 were determined using ImageJ software and were normalized to corresponding actin levels.
RESULTS
TRPC channels are present in adult rat sensory neurons. First, we used specific primers for rat TRPC1 and TRPC3-TRPC7 to determine whether DRG neurons express TRPC channels. Our RT-PCR analysis showed that variable levels of TRPC1, TRPC3, TRPC4, TRPC5 and TRPC6 were expressed in dorsal root ganglia ( Fig. 1A) . TRPC7 was not detected in 3 separate tests. Quantitative real-time PCR assays were performed using SYBR ® Green and absolute copy numbers of various TRPC channels were calculated. We found that TRPC4 and TRPC5 appeared to be most abundant, followed by TRPC1 and TRPC3.
TRPC6 and TRPC7 mRNAs were at much lower concentrations ( Fig.  1B) .
Next, we examined TRPC4 protein expression in adult rat ganglia using immunohistochemical labeling. TRPC4 immunoreactivity was detected in approximately 55% of total DRG neurons as identified by Hoechst staining. Schwann cells and satellite cells were weakly labeled with TRPC4. Staining with N52 and P2X 3 or CGRP was used to label large and small neurons associated with myelinated or unmyelinated fibers. Figure 1C shows representative images of DRG cryosections triple labeled with TRPC4, N52 and P2X 3 . The combined image shows TRPC4 immunoreactivity in different DRG subpopulations. Quantitative analysis showed that 38±3% (n=316) of N52-positive neurons were TRPC4 immunoreactive and 75±6% (n=300) of P2X 3 -positive neurons were TRPC4 immunoreactive.
Approximately 69±5% (n=258) of CGRP-positive neurons were TRPC4-positive.
TRPC4 transcript is increased following nerve injury and db-cAMP injection. We have previously reported that both sciatic nerve axotomy and db-cAMP-microinjection accelerate axonal regeneration after crush injury of the corresponding dorsal spinal nerve root (15) . Here we found that the transcript levels of TRPC4 and TRPC5 were increased to 357±20% (n=3, p<0.001) and 186±14% (p<0.01, n=3) 2 days after nerve injury. Microinjection of db-cAMP upregulated TRPC4 to 223±35%, (p<0.01, n=3), but had no effect on TRPC5 (107±21%, p>0.05, n=3). TRPC1, TRPC3, TRPC6 and TRPC7 were not markedly altered following sciatic nerve transection or db-cAMPinjection ( Fig. 2A) .
Next, we examined transcript levels of TRPC subunits at day 7 and 14 after a priming lesion in the left sciatic nerve (Fig. 2B) .
The concentration of TRPC4 transcript peaked at 2d and fell to 56±5% (n=3, p<0.05) and 43±1% (n=3, p<0.001) at 7d and 14d. TRPC5 mRNA was halved at 7d (79±14%, n=3, p>0.05) when compared with that of 2d, but was not further reduced at 14d (76±11%, n=3 p>0.05). Transcripts of TRPC1, TRPC3 and TRPC6 were not significantly changed from 2d to7d after nerve injury. However, TRPC7 mRNA levels were reduced to 70±5% (n=3, p<0.01) at 7d and 38±4% (n=3, p<0.001) at 14d. Thus, nerve injury elicited a transient increase in TRPC4 and a significant reduction in TRPC7.
TRPC4 protein was analyzed in L4 and L5 DRG at days 4, 7 and 14 following nerve injury. A single band of molecular weight of approximately 100 kDa was detected by rabbit TRPC4 polyclonal antibody (Fig. 2C ). TRPC4 protein levels were expressed in relation to the loading control of actin using ImageJ analysis. TRPC4 protein was increased by 2.1-fold and 3fold at 4d and 7d, and reduced to control level at day 14 after nerve injury.
TRPC4 mRNA is substantially increased in differentiated NDC and ND7/23 cells. Figure 3A shows naïve and differentiated ND7/23 cells visualized under phase-contrast illumination. Naïve ND7/23 cells gave rise to short neurites 2 days after plating. In the presence of NGF (100 ng/ml) or db-cAMP (1 mM), cells stopped proliferating and generated long unbranched neurites. RT-PCR analyses were carried out on naïve and differentiated NDC and ND7/23 cells, and in naïve and differentiated PC12 cells. Figure 3B shows representative results from one of three similar experiments. Transcripts for TRPC1, TRPC4, and TRPC5-7 were found in naïve and differentiated NCD cells, while transcripts for TRPC3-7 were found in naïve and differentiated ND7/23 cells.
A discernible increase in TRPC4 mRNA was observed in differentiated NDC and ND7/23 cells, and a marked reduction in TRPC7 mRNA was observed in differentiated ND7/23 cells. In contrast, transcripts of TRPC1 and TRPC3-7 were found in both naïve and differentiated PC12 cells and no discernible changes were observed.
We further quantified changes in TRPC1 and TRPC3-7 transcripts in naïve and differentiated NDC and ND7/23 cells using SYBR Green (Fig.  3C ). TRPC4 transcript was increased by approximately 10-fold and 13-fold in NDC cells after stimulation with NGF or db-cAMP for 2 days. An increase in TRPC4 mRNA of approximately 3-fold and 7-fold was observed in differentiated ND7/23 cells. TRPC1 was not detected in ND7/23 cells and not markedly changed in NDC cells. TRPC3 was not detected in NDC cells and moderately increased in ND7/23 cells stimulated with NGF (1.6-fold) or db-cAMP (2.4-fold). A 3-fold increase in TRPC5 mRNA was observed in differentiated NDC cells, but no marked increase was observed in ND7/23 cells.
db-cAMP increased the TRPC6 mRNA level by 3.5-fold in NDC cells and 2-fold in ND7/23 cells, whereas NGF did not markedly alter TRPC6 transcript in NDC and ND7/23 cells. A moderate increase of 2-fold was observed in TRPC7 mRNA in NDC cells treated with NGF, but not with db-cAMP. However, NGF and db-cAMP reduced the level of TRPC7 mRNA by approximately 80% in ND7/23 cells.
TRPC4 is present in the growth cone of cultured DRG neurons. To examine TRPC4 expression during different stages of neurite outgrowth, we fixed DRG neurons at 6, 12, 24 and 48 hrs after plating. Figure 4 shows confocal microscopic images of outgrowth of neurites at various stages from membrane expansion ( Subsequently, some neurites were selected for extension by a mechanism that is not fully understood.
We found that membranous expansions and filopodia were positively stained for TRPC4. Longer neurites appeared to be more intensely labeled with TRPC4 than shorter neurites of the same neurons (Figs. 4D & E) , an observation suggesting that TRPC4 was selectively enriched in elongating neurites. TRPC4 immunoreactivity was also found in all naïve and differentiated ND7/23 cells stimulated with db-cAMP (Figs. 4F & G). TRPC4 staining as irregular punctae was present in the cell membrane, in the cytosol, along the neuronal process and in finger-like projections characteristic of growth cones.
Nerve injury increases TRPC4immunoreactive DRG neurons.
Immunostaining of tissue sections was carried out to determine whether the increased TRPC4 expression observed in DRG after nerve injury occurs in neurons or glia. TRPC4
immunoreactivity increased from approximately 50% of DRG neurons to 70% from 12hrs to 3d after sciatic nerve axotomy (p<0.01, Fig. 5A ).
Schwann cells weakly express TRPC4
however the increase in the percentage of TRPC4-positive Schwann cells was negligible (24% vs 25%). To investigate in which subpopulations of DRG neurons TRPC4 immunoreactivity was increased, we compared the total cell size distribution and TRPC4positive cell size distribution at 12hrs and 3d after nerve transection (Figs. 5B & C). Previous studies indicate that cells larger than 1000 μm 2 in area correspond to cells with myelinated axons and Aα/β conduction velocities (22) . Thus, we adopted 1000 μm 2 as a cutoff point to distinguish small-and large-sized neurons. It appears that nerve injury shifted the distribution of TRPC4-positive cells toward large-sized neurons. Approximately half of TRPC4-positive neurons (49.2%) were in the category of large cells at 3d postoperatively compared with about a quarter of TRPC4 positive neurons (24.4%) at 12 hrs. Changes in the TRPC4 expression profile in DRG subpopulations were confirmed when we triple labeled DRG sections for TRPC4, N52 and P2X 3 /CGRP immunoreactivty. Three days after sciatic nerve injury, approximately 63% of large myelinated neurons indicated by N52 staining (n=134) were TRPC4 immunoreactive positive.
Of small unmyelinated neurons identified by P2X 3 or CGRP staining, approximately 81% or 86% respectively were TRPC4 immunoreactive.
Suppression of TRPC4 mRNA inhibits the elongation of neurites in ND7/23 cells. Figure  6A shows TRPC4 staining in naïve and differentiated ND7/23 cells expressing either a scrambled sequence (control) or TRPC4-specific shRNA. shRNA-expressing cells showed discernible weak TRPC4 immunoreactivity in three separate preparations. Using a previously identified shRNA specifically targeting TRPC4 (17), we were able to suppress TRPC4 mRNA by 74% measured by real-time PCR (Fig. 6B) . The control shRNA with scrambled sequence had no effect on TRPC4 expression. TRPC4 transcript levels were normalized to that of control cells in the absence of NGF or db-cAMP. In the presence of NGF or db-cAMP, TRPC4 mRNA in shRNA-expressing cells was approximately 23% and 20% when compared with that of control cells. The length of neurites was markedly reduced in shRNA-expressing cells. In control ND7/23 cells, median neurite lengths in the presence of NGF or db-cAMP were 17.4 and 39.1 μm, as compared to 9.5 μm in undifferentiated cells. In shRNA-expressing cells, median neurite lengths in the presence of NGF or db-cAMP were 12.7 and 16.5 μm, as compared to 10.4 μm in the un-stimulated condition (Fig. 6C) . The distribution of neurite lengths for control and shRNA-expressing cells in the absence of NGF or db-cAMP was not significantly different by the χ 2 test. In contrast, distribution of neurite lengths for control cells stimulated by NGF or db-cAMP differed with high significance from that for shRNAexpressing cells (p<0.01).
Over-expression of human TRPC4 rescues neurite shortening in shRNA-expressing cells.
The sequence of human TRPC4 (hTRPC4) contains a 2 nucleotide mismatch when compared with that of shRNA targeting rat TRPC4.
We examined whether overexpression of hTRPC4 could rescue neurite shortening in shRNA-expressing ND7/23 cells. Transfection efficiency of hTRPC4 was approximately 80% as estimated by GFP expression (Fig. 7A) . We found that almost all GFP-positive cells in three separate preparations were labeled with TRPC4 immunoreactivity (Figs. 7A & B) . In contrast, shRNA-expressing cells displayed either no or weak TRPC4 staining. Following the incubation with NGF or db-cAMP for 48 hrs, the length of neurites in shRNA-expressing cells and TRPC4/shRNA-expressing cells was measured after β-tubulin staining (Fig. 7C) . neurite length from 12.7 and 16.5 μm to 16.2  and 34.2 μm (Fig. 7D) . Distribution of neurite lengths for hTRPC4/shRNA expressing cells significantly differed from that for shRNAexpressing cells upon differentiation with db- cAMP (p<0.001, χ 2 test) . The median lengths of control ND7/23 cells in the presence of NGF or db-cAMP were 17.4 and 39.1 μm. Thus, it appeared that over-expression of hTRPC4 reversed, at least partially, the impairment of neurite elongation caused by shRNA expression.
In the presence of NGF or db-cAMP, overexpression of hTRPC4 increased the median
Inhibition of TRPC4 impairs neurite outgrowth in DRG neurons. Fluorescein-labeled TRPC4 siRNA and scrambled RNA duplex were tested in cultured DRG neurons. A transfection rate of 60% was routinely achieved (Fig. 8A) and transfection had no effects on cell survival during 2 days determined by trypan blue staining. The efficacy of TRPC4-specific siRNA was validated with Western blotting analysis (Fig. 8B) . Levels of TRPC4 protein in DRG transfected with scrambled or siRNA were expressed in relation to the loading control of actin and were normalized to the level of the control preparation. TRPC4-specific siRNA repressed TRPC4 expression to 23.6±1% of controls (n=3, p<0.01, Student t test), while the scrambled RNA duplexes had no significant effect on TRPC4 expression ( Fig. 8C ). We found that the elongation of neurites was markedly impaired in neurons transfected with TRPC4specific siRNA (Fig. 8D) . The median neurite length in DRG neurons transfected with TRPC4specific siRNA was 116.9 μm (with a 95% confidence range of 97.5 μm to 136.0 μm, n=92), while that in control preparations was 234.9 μm (with 95% confidence range of 223.6 μm to 270.3 μm, n= 96, Fig. 8E ). The distribution of neurite lengths for control and scrambled siRNA preparations was not significantly different by the χ 2 test. In contrast, distribution of neurite lengths for DRG transfected with TRPC4-sepcific siRNA differed with high significance from that of control cells (Fig. 8F, p<0.001, χ 2 test) .
A recent publication showed that the growth and maintenance of synapses and dendritic spines were sensitive to off-target effects of siRNA (23). To corroborate our findings from siRNA experiments, we employed a previously identified antisense to knockdown TRPC4 expression in DRG neurons (20) . 5'-fluorescein was used as a marked for oligonucleotide-positive neurons. We found that transfection efficiency for oligonucleotide primers was approximately 80% in DRG cells (Figs. 9A & B) . Using antisense specifically targeting TRPC4, we were able to suppress TRPC4 mRNA by 89% measured by real-time PCR (Fig. 9C) . Sense and scrambled oligonucleotides had no significant effect on the level of TRPC4 transcript expressed as percentage of that of control neurons after normalization to the corresponding level of 18s rRNA. The median neurite length in DRG neurons transfected with TRPC4 antisense was 125.2 μm with a 95% confidence range of 98.4 μm to 136.9 μm (n=86), as compared to 240.8 μm in control DRG preparations with a 95% confidence range of 215.6 to 274.8 μm (n= 71).
DISCUSSION
Several lines of evidence indicate a potential functional role of TRPC4 in axonal regeneration. TRPC4 transcript and protein are increased in the DRG after sciatic nerve transection. By immunohistochemistry, at least some of the increased TRPC4 is found in neurons, particularly large-sized ones. In cultured sensory neurons, TRPC4 is present along the process of neurites and is present in growth cones. Most directly, suppression of TRPC4 synthesis by specific siRNA or antisense halves the median length of neurites in DRG neurons. Thus, the temporal and spatial distributions of TRPC4 in injured neurons, together with the functional data strongly suggest that TRPC4 contributes to axonal regeneration in primary sensory neurons after injury.
Microarray studies have revealed that over 200 genes including those coding for ion channels, G protein-coupled receptors, cytokines/growth factors, cell cytoskeleton and transcription factors are altered in injured DRG neurons (24) (25) (26) . Here, we report that TRPC channels are present in mammalian sensory neurons and that TRPC4 is increased after nerve injury. Genes that have been identified in array studies show a diverse pattern over time, probably reflecting their different functions in fast adaptive response, survival, regeneration or neuropathic pain. In addition to TRPC4, other molecules such as interleukin-6 (IL-6) and heat shock protein 27 (Hsp27) also undergo a transient increase after nerve injury (24, 25, 27) . For example, IL-6, which is undetectable after development, reappears within 1 d, maximally increases between 2d and 4d, and decreases below the detection threshold within 7d after nerve injury (27) . The beneficial effect of IL-6 is thought to be due to the induction of BDNF in injured sensory neurons and the role of Hsp27 on various stages of neurite outgrowth is probably due to the modulation of actin cytoskeletal dynamics (28, 29) . TRPC4 induction is likely to have a related function to other proteins in DRG neurons that are increased over the same time course.
TRPC receptors are Ca 2+ -permeable cation channels that are activated downstream of PLCβ or PLCγ following stimulation of G-proteincoupled receptors or receptor tyrosine kinases. The precise mechanisms by which TRPC4 is activated are not fully understood. Recent studies have shed light on the mechanisms underlying the activation of TRPC channels by growth factors.
For example, TRPC3 is activated by BDNF via a PLCγ-IP 3 R pathway in CNS neurons (9) . TRPC5 is present in neuronal cytoplasmic transport vesicles and its activation is controlled by epidermal growth factor and BDNF through control of rapid vesicular translocation and insertion (30, 31) . BDNF synthesis and anterograde transport are increased in large diameter DRG neurons within 24 hrs after sciatic nerve injury (24, 25, 32, 33) . Thus, it is likely that TRPC4 activity in growth cones is enhanced by an increased release of growth factors after nerve injury.
In the nerve cell body, elevation of intracellular Ca 2+ following TRPC4 activation might regulate numerous physiological processes through a wide range of target proteins such as cAMP response element binding protein (CREB) and mitogen-activated protein kinase (MAPK)/extracellular-regulated kinase (ERK) that in turn regulate gene expression (34, 35) . Beneficial effects of TRPC4 on the neurite outgrowth might also be exerted through Rho GTPases, a family of small GTP-binding proteins encompassing Rho, Rac, and Cdc42 subfamilies. Recent studies have revealed a close relationship between TRPC channels and the activation of RhoA (36, 37) . For example, TRPC6-mediated Ca 2+ influx induces RhoA activation and results in endothelial cell contraction (37) . In the growth cone, Ca 2+ also plays a key role in regulating cytoskeletal molecules and membrane dynamics via various signaling molecules such as the growth associated protein GAP43 (2, 38, 39) . Previous studies have shown that GAP43 like proteins promote neurite outgrowth, anatomical plasticity and nerve regeneration by modulating PIP 2 (phosphatidylinositol 4,5-bisphosphate) at plasmalemmal rafts (40) . GAP43-like proteins contain a basic domain that binds calcium/calmodulin, actin filaments, PKC (protein kinase C) and PIP 2 (41) . Ca 2+ entering the cytoplasm upon the activation of the TRPC4 channel could bind calmodulin and interact with the basic domain of GAP43, which could result in actin cytoskeleton remodeling.
Further studies are required to examine the downstream signaling pathways of TRPC4 and to understand the mechanism by which TRPC4 enhances neurite outgrowth.
Our results have shown that suppression of TRPC4 through shRNA, siRNA and antisense reduces the length of neurites in ND7/23 cells and adult DRG neurons. The specificity of this suppression was established using appropriate scrambled or sense controls, and by showing that the over-expression of hTRPC4 overcomes the suppression due to shRNA (23) . Interestingly, previous studies show that dominant-negative TRPC5 expression promotes neurite outgrowth and filopodia formation in hippocampal neurons (30, 31) . These data indicate that the functions of TRPC channels depend on the specific assembly of TRPC subunits, the tissue type and the age of animals. TRPC expression in various cell types typically is not limited to a single member, but a combination of various TRPC subunits (18, (42) (43) (44) . In addition, the TRPC expression profile changes during development. For example, TRPC4 is significantly reduced during postnatal development of the cerebellum (45) .
It has been found that the TRPC4 subunits can form heteromeric channels within a given structural subfamily such as with TRPC5, and beyond the structural subfamily as with TRPC1 and TRPC3 (46) (47) (48) (49) . Thus, reduction of TRPC4 expression by specific shRNA or siRNA might affect the function of both TRPC4 homomers and TRPC4containing heteromers and the impairment of neurite elongation might be an overall consequence of the reduction of more than one assembly.
Our data strongly suggest an important role of TRPC4 in sensory axonal regeneration and establish TRPC4 as a potential therapeutic target for promoting regeneration after nerve injury.
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The abbreviations used are: db-cAMP, dibutyryl cyclic adenosine monophosphate; DRG, dorsal root ganglion; siRNA, small interfering RNA; shRNA; short hairpin RNA; TRPC, canonical transient receptor potential receptor. Fig. 1 . TRPC channels are present in adult DRG neurons. A. RT-PCR products of mRNA isolated from adult rat DRG are shown using primers for TRPC1, TRPC3-TRPC7 and 18S rRNA. B. Relative levels of different TRPC transcripts determined by quantitative real-time PCR and expressed as absolute copy numbers normalized to those of 18S rRNA. C. Immunohistochemical staining of TRPC4, N52 and P2X 3 in rat DRG cryosections. Neurons double labeled with TRPC4 and N52 are indicated by an asterisk and those with TRPC4 and P2X 3 by an arrow in the combined image. The scale bar represents 50 μm. Fig. 2 . TRPC4 is transiently upregulated during regenerative conditions. A. TRPC mRNA levels in L4 and L5 DRG at day 2 following either left sciatic nerve injury or intra-ganglionic microinjection of db-cAMP. Transcript levels of TRPC subunits from rats with nerve injury were expressed in relation to that of mock axotomy and the latter was designated as 1. TRPC levels in db-cAMP-injected DRG were expressed in relation to that of PBS-injected DRG. B. TRPC transcript levels at day 7 and 14 after sciatic nerve axotomy. Data of TRPC levels at postoperative day 2 are shown for comparison. *** p<0.001, **p<0.01, *p<0.05 compared to control (A) and compared to 2 days (B), unpaired Student's t test. C. Western blotting analysis for TRPC4 and actin at days 4, 7 and 14 after nerve injury. Changes in TRPC subunits in differentiated NDC and ND7/23 cells determined by quantitative RT-PCR. mRNA levels of TRPC channels in differentiated cells were normalized to those in naïve cells and the latter was designated as 1 (*** p<0.001 and **p<0.01, Student's t test). Fig. 4 . TRPC4 is present in the growth cone in adult sensory neurons. Representative confocal microscopic images show outgrowth of neurites at various stages: membranous expansion (A), neurite formation (B, C) and elongation (D, E). TRPC4 immunoreactivity was found in the cell membrane, in the cytosol, along the neurite process and in the growth cone of DRG neurons. Naïve (F) and differentiated (G) ND7/23 cells were also immunoreactive for TRPC4. Scale bars, 20 μm. 6 . Down-regulation of TRPC4 using specific shRNA impairs neurite outgrowth in ND7/23 cells. A. TRPC4 staining in control (scrambled shRNA) and shRNA-expressing ND7/23 cells in the presence and absence of NFG or db-cAMP. shRNA-expressing cells showed weak TRPC4 immunoreactivity and bore short neurites. Scale bar, 50 μm. B. Real-time RT-PCR analysis of TRPC4 in control and shRNA-expressing cells in naïve, NGF-and db-cAMP-treated cells. shRNA reduces the concentrations of TRPC4 mRNA in comparison to that of naïve ND7/23 cells in the absence or presence of NGF/db-cAMP (*** p<0.001 and **p<0.01, Student's t test). C. Summary of median lengths and 95% confidence levels in control and shRNA-expressing cells in the absence and presence of NGF or db-cAMP. In NGF or db-cAMP treated cultures, shRNA reduces median neurite length compared to controls. D. Frequency histogram showing the percentage of cells with neurites in each of the three length ranges (n=200-350). In the presence of NGF or db-cAMP, the distribution of neurite lengths for control cells differs significantly from that for shRNA-expressing cells by χ 2 analysis (p<0.01 and p<0.001 respectively). with scrambled or TRPC4 siRNA. siRNA transfected cells show greatly reduced neurites compared to scrambled controls. Scale bar, 100 μm. E. Median lengths and the 95% confidence ranges of the longest neurites in cultured sensory neurons transfected with scrambled or TRPC4 siRNA. siRNA transfected cells show greatly reduced median neurite length compared to controls. F, Frequency histogram showing the percentage of cells with neurites in each of the seven length ranges (n=~100). The distribution of neurite lengths for cells transfected with TRPC4 siRNA differs significantly from that for cells transfected with scrambled RNA duplexes (p<0.001, χ 2 analysis). 
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